The Thai Network of People Living with HIV/AIDS (TNP+) has called on Public Health Minister Somsak Thepsuthin to improve the ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Winning Founding Managing Editor and Executive Director of Cns (Citizen News Service) and Is a Feminist, Health and Development Justice Advocate.Scientific research has gifted us with a range of ...

Gilead said the price is comparable to existing HIV prevention drugs and the company will work with ... Peru, South Africa and Thailand. Schmid said the studies show people are much more likely to ...

As U.S. HIV/AIDS aid wanes, Thailand thrives with local leadership and community care — offering a model for others amid a global funding crisis.

"To end AIDS as a public health emergency we need a far stronger focus on prevention, and not just on keeping people living with HIV alive and well. New infections are like a leaking tap - "every drop ...

Although world is not on track to end AIDS by 2030 but it is no less than a miracle when we take into account the scientific ...

Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income countries gain access?

The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.. The drug will be ...

The Centers for Disease Control and Prevention estimated in May that between 2018 and 2022, annual U.S. HIV transmissions declined by a modest 12%, from 36,200 to 31,800 cases.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. FDA approves new twice-yearly HIV shot. What to know ...